$460,000 of ACCENTURE LLP lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to domestic and international tax; H.R. 1, 2025 Budget Reconciliation Bill Artificial Intelligence; Tech/Workforce issues; Government procurement issues; Government IT efficiency and IT modernization; Banking and Financial Services issues; sustainability issues. Cybersecurity: public/private partnerships; Cyber workforce; critical infrastructure regulations; space security Workforce Development issues (WIOA and apprenticeships); Artificial Intelligence issues; Emerging Technology and Workforce issues Government technology transformation Issues related to Medicaid, SNAP, and Rural Health Transformation Program: H.R. 1, 2025 Budget Reconciliation Bill Permitting reform; grid modernization"
You can find more data on corporate lobbying on Quiver Quantitative.
ACN Congressional Stock Trading
Members of Congress have traded $ACN stock 12 times in the past 6 months. Of those trades, 1 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $ACN stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 12/19.
- REPRESENTATIVE KEVIN HERN has traded it 2 times. They made 0 purchases and 2 sales worth up to $300,000 on 10/27, 09/26.
- SENATOR MARKWAYNE MULLIN sold up to $50,000 on 09/24.
- REPRESENTATIVE RICK W. ALLEN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 09/12, 08/19.
- REPRESENTATIVE KELLY MORRISON has traded it 5 times. They made 0 purchases and 5 sales worth up to $145,000 on 08/19.
- REPRESENTATIVE JULIA LETLOW sold up to $15,000 on 07/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ACN Insider Trading Activity
ACN insiders have traded $ACN stock on the open market 34 times in the past 6 months. Of those trades, 0 have been purchases and 34 have been sales.
Here’s a breakdown of recent trading of $ACN stock by insiders over the last 6 months:
- JULIE SPELLMAN SWEET (Chair and CEO) has made 0 purchases and 20 sales selling 25,611 shares for an estimated $6,474,409.
- MANISH SHARMA (Chief Strategy & Services Ofcr) has made 0 purchases and 8 sales selling 9,633 shares for an estimated $2,512,417.
- RYOJI SEKIDO (Co-CEO Asia Pacific) has made 0 purchases and 3 sales selling 2,500 shares for an estimated $623,674.
- JOEL UNRUCH (General Counsel/Corp Secretary) sold 1,332 shares for an estimated $366,300
- MAURO MACCHI (Chief Executive Officer-EMEA) has made 0 purchases and 2 sales selling 1,000 shares for an estimated $280,000.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ACN Hedge Fund Activity
We have seen 959 institutional investors add shares of ACN stock to their portfolio, and 1,263 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS added 4,984,930 shares (+41.1%) to their portfolio in Q3 2025, for an estimated $1,229,283,738
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,721,245 shares (+53.6%) to their portfolio in Q3 2025, for an estimated $917,659,017
- PRICE T ROWE ASSOCIATES INC /MD/ removed 3,554,097 shares (-45.9%) from their portfolio in Q3 2025, for an estimated $876,440,320
- CAPITAL RESEARCH GLOBAL INVESTORS removed 2,725,188 shares (-32.4%) from their portfolio in Q3 2025, for an estimated $672,031,360
- AMERIPRISE FINANCIAL INC removed 2,158,227 shares (-42.6%) from their portfolio in Q3 2025, for an estimated $532,218,778
- MORGAN STANLEY removed 1,940,988 shares (-13.9%) from their portfolio in Q3 2025, for an estimated $478,647,640
- CLEARBRIDGE INVESTMENTS, LLC removed 1,906,435 shares (-99.0%) from their portfolio in Q3 2025, for an estimated $470,126,871
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ACN Analyst Ratings
Wall Street analysts have issued reports on $ACN in the last several months. We have seen 9 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 12/19/2025
- RBC Capital issued a "Outperform" rating on 12/19/2025
- Mizuho issued a "Outperform" rating on 09/29/2025
- JP Morgan issued a "Overweight" rating on 09/26/2025
- Baird issued a "Outperform" rating on 09/26/2025
- Guggenheim issued a "Buy" rating on 09/26/2025
- Evercore ISI Group issued a "Outperform" rating on 09/26/2025
To track analyst ratings and price targets for ACN, check out Quiver Quantitative's $ACN forecast page.
ACN Price Targets
Multiple analysts have issued price targets for $ACN recently. We have seen 19 analysts offer price targets for $ACN in the last 6 months, with a median target of $290.0.
Here are some recent targets:
- Jason Kupferberg from Wells Fargo set a target price of $275.0 on 01/14/2026
- Arvind Ramnani from Truist Securities set a target price of $317.0 on 01/06/2026
- James Friedman from Susquehanna set a target price of $277.0 on 12/19/2025
- Daniel R. Perlin from RBC Capital set a target price of $295.0 on 12/19/2025
- Kevin Mcveigh from UBS set a target price of $320.0 on 12/19/2025
- James Faucette from Morgan Stanley set a target price of $320.0 on 12/16/2025
- Bryan Keane from Citigroup set a target price of $266.0 on 10/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
